Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration

Bibliographic Details
Main Author: Di Zhang
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:The Journal of Clinical Hypertension
Online Access:https://doi.org/10.1111/jch.14538
_version_ 1797645213508829184
author Di Zhang
author_facet Di Zhang
author_sort Di Zhang
collection DOAJ
first_indexed 2024-03-11T14:43:07Z
format Article
id doaj.art-295de5e8dffd49f3bf6114d52f665b26
institution Directory Open Access Journal
issn 1524-6175
1751-7176
language English
last_indexed 2024-03-11T14:43:07Z
publishDate 2022-08-01
publisher Wiley
record_format Article
series The Journal of Clinical Hypertension
spelling doaj.art-295de5e8dffd49f3bf6114d52f665b262023-10-30T13:26:05ZengWileyThe Journal of Clinical Hypertension1524-61751751-71762022-08-012481076107810.1111/jch.14538Treatment for hyperuricemia and gout in Japan: Aspect of prescription and durationDi Zhang0Rehabilitation Medicine Center Zhongshan Hospital Fudan University Shanghai Chinahttps://doi.org/10.1111/jch.14538
spellingShingle Di Zhang
Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration
The Journal of Clinical Hypertension
title Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration
title_full Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration
title_fullStr Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration
title_full_unstemmed Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration
title_short Treatment for hyperuricemia and gout in Japan: Aspect of prescription and duration
title_sort treatment for hyperuricemia and gout in japan aspect of prescription and duration
url https://doi.org/10.1111/jch.14538
work_keys_str_mv AT dizhang treatmentforhyperuricemiaandgoutinjapanaspectofprescriptionandduration